These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 15058585)

  • 1. Determination of midazolam and its metabolite as a probe for cytochrome P450 3A4 phenotype by liquid chromatography-mass spectrometry.
    Kanazawa H; Okada A; Igarashi E; Higaki M; Miyabe T; Sano T; Nishimura R
    J Chromatogr A; 2004 Mar; 1031(1-2):213-8. PubMed ID: 15058585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A developed determination of midazolam and 1'-hydroxymidazolam in plasma by liquid chromatography-mass spectrometry: application of human pharmacokinetic study for measurement of CYP3A activity.
    Shimizu M; Uno T; Tamura HO; Kanazawa H; Murakami I; Sugawara K; Tateishi T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Mar; 847(2):275-81. PubMed ID: 17085083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propofol decreases the clearance of midazolam by inhibiting CYP3A4: an in vivo and in vitro study.
    Hamaoka N; Oda Y; Hase I; Mizutani K; Nakamoto T; Ishizaki T; Asada A
    Clin Pharmacol Ther; 1999 Aug; 66(2):110-7. PubMed ID: 10460064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liquid chromatography/tandem mass spectrometry method for simultaneous evaluation of activities of five cytochrome P450s using a five-drug cocktail and application to cytochrome P450 phenotyping studies in rats.
    Zhang S; Song N; Li Q; Fan H; Liu C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Aug; 871(1):78-89. PubMed ID: 18614408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a LC-MS/MS method for the in vitro analysis of 1-hydroxymidazolam in human liver microsomes: application for determining CYP3A4 inhibition in complex matrix mixtures.
    Mooiman KD; Maas-Bakker RF; Rosing H; Beijnen JH; Schellens JH; Meijerman I
    Biomed Chromatogr; 2013 Sep; 27(9):1107-16. PubMed ID: 23674377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid and simultaneous measurement of midazolam, 1'-hydroxymidazolam and digoxin by liquid chromatography/tandem mass spectrometry: application to an in vivo study to simultaneously measure P-glycoprotein and cytochrome P450 3A activity.
    Xue X; Huang M; Xiao H; Qin X; Huang L; Zhong G; Bi H
    J Pharm Biomed Anal; 2011 Apr; 55(1):187-93. PubMed ID: 21316177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of omeprazole and its metabolites in human plasma by liquid chromatography-mass spectrometry.
    Kanazawa H; Okada A; Matsushima Y; Yokota H; Okubo S; Mashige F; Nakahara K
    J Chromatogr A; 2002 Mar; 949(1-2):1-9. PubMed ID: 11999727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of parecoxib, a parenteral cyclooxygenase-2 specific inhibitor, on the pharmacokinetics and clinical effects of midazolam.
    Ibrahim A; Karim A; Feldman J; Kharasch E
    Anesth Analg; 2002 Sep; 95(3):667-73, table of contents. PubMed ID: 12198057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of femtomolar concentrations of the CYP3A substrate midazolam and its main metabolite 1'-hydroxymidazolam in human plasma using ultra performance liquid chromatography coupled to tandem mass spectrometry.
    Burhenne J; Halama B; Maurer M; Riedel KD; Hohmann N; Mikus G; Haefeli WE
    Anal Bioanal Chem; 2012 Mar; 402(7):2439-50. PubMed ID: 22252655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of midazolam and its hydroxy metabolites in human plasma and oral fluid by liquid chromatography/electrospray ionization ion trap tandem mass spectrometry.
    Link B; Haschke M; Wenk M; Krähenbühl S
    Rapid Commun Mass Spectrom; 2007; 21(9):1531-40. PubMed ID: 17410605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of a rapid and sensitive assay for simultaneous quantification of midazolam, 1'-hydroxymidazolam, and 4-hydroxymidazolam by liquid chromatography coupled to tandem mass-spectrometry.
    Dostalek M; Macwan JS; Chitnis SD; Ionita IA; Akhlaghi F
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jun; 878(19):1629-33. PubMed ID: 20434409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous determination of probe drugs, metabolites, inhibitors and inducer in human plasma by liquid chromatography/tandem mass spectrometry and its application to pharmacokinetic study.
    Hee KH; Yao Z; Lee LS
    J Pharm Biomed Anal; 2014 Jan; 88():584-93. PubMed ID: 24211708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of midazolam in human plasma by liquid chromatography with mass-spectrometric detection.
    Lepper ER; Hicks JK; Verweij J; Zhai S; Figg WD; Sparreboom A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Jul; 806(2):305-10. PubMed ID: 15171944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HPLC determination of midazolam and its three hydroxy metabolites in perfusion medium and plasma from rats.
    Jurica J; Dostálek M; Konecný J; Glatz Z; Hadasová E; Tomandl J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 852(1-2):571-7. PubMed ID: 17350905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-drug interactions and metabolism in cytochrome P450 2C knockout mice: application to troleandomycin and midazolam.
    Grimsley A; Gallagher R; Hutchison M; Pickup K; Wilson ID; Samuelsson K
    Biochem Pharmacol; 2013 Aug; 86(4):529-38. PubMed ID: 23732297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmaceutical excipients inhibit cytochrome P450 activity in cell free systems and after systemic administration.
    Ren X; Mao X; Si L; Cao L; Xiong H; Qiu J; Schimmer AD; Li G
    Eur J Pharm Biopharm; 2008 Sep; 70(1):279-88. PubMed ID: 18499414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of correlation between in vitro and in vivo studies on the effects of tangeretin and tangerine juice on midazolam hydroxylation.
    Backman JT; Mäenpää J; Belle DJ; Wrighton SA; Kivistö KT; Neuvonen PJ
    Clin Pharmacol Ther; 2000 Apr; 67(4):382-90. PubMed ID: 10801247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of an LC-MS/MS Method for the Determination of Propofol, Midazolam, and Carbamazepine in Rat Plasma: Application to Monitor Their Concentrations Following Co-administration.
    El Hamd MA; Wada M; Ikeda R; Kawakami S; Nakashima K
    Biol Pharm Bull; 2015; 38(8):1250-3. PubMed ID: 26235591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regioselective biotransformation of midazolam by members of the human cytochrome P450 3A (CYP3A) subfamily.
    Gorski JC; Hall SD; Jones DR; VandenBranden M; Wrighton SA
    Biochem Pharmacol; 1994 Apr; 47(9):1643-53. PubMed ID: 8185679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A highly sensitive liquid chromatography tandem mass spectrometry method for simultaneous quantification of midazolam, 1'-hydroxymidazolam and 4-hydroxymidazolam in human plasma.
    de Loor H; de Jonge H; Verbeke K; Vanrenterghem Y; Kuypers DR
    Biomed Chromatogr; 2011 Oct; 25(10):1091-8. PubMed ID: 21204116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.